Alfred  Lumsdaine net worth and biography

Alfred Lumsdaine Biography and Net Worth

With more than 30 years of healthcare finance experience, Alfred Lumsdaine provides financial oversight across all organization activities and assets. He develops and executes Ardent’s long-range financial plans, leads short and long-term capital strategies and ensures proper internal controls.

Previously, Mr. Lumsdaine served as executive vice president and CFO of Quorum Health Corporation. In this role, he oversaw financial operations for the system's acute care hospitals and led a major financial restructuring and other strategic initiatives that significantly reduced the company’s debt and improved its financial position. Prior to joining Quorum Health in 2018, Mr. Lumsdaine was president of Population Health for Sharecare and spent five years as CFO for Tivity Health prior to its acquisition by Sharecare. He began his career at Ernst & Young where he spent more than eight years in the external audit practice with a focus on healthcare.

A Certified Public Accountant (CPA), Mr. Lumsdaine earned both an undergraduate and a master’s degree in accounting from the University of Tennessee.

What is Alfred Lumsdaine's net worth?

The estimated net worth of Alfred Lumsdaine is at least $2.90 million as of June 5th, 2026. Lumsdaine owns 329,183 shares of Ardent Health stock worth more than $2,901,419 as of June 8th. This net worth estimate does not reflect any other investments that Lumsdaine may own. Learn More about Alfred Lumsdaine's net worth.

How do I contact Alfred Lumsdaine?

The corporate mailing address for Lumsdaine and other Ardent Health executives is ONE BURTON HILLS BLVD, SUITE 250, NASHVILLE, TN, 37215. Ardent Health can also be reached via phone at (615) 296-3000 and via email at [email protected]. Learn More on Alfred Lumsdaine's contact information.

Has Alfred Lumsdaine been buying or selling shares of Ardent Health?

In the last ninety days, Alfred Lumsdaine has bought $88,100.00 in Ardent Health stock. Most recently, on Friday, June 5th, Alfred Lumsdaine bought 10,000 shares of Ardent Health stock. The stock was acquired at an average cost of $8.81 per share, with a total value of $88,100.00. Following the completion of the transaction, the chief financial officer now directly owns 329,183 shares of the company's stock, valued at $2,900,102.23. Learn More on Alfred Lumsdaine's trading history.

Are insiders buying or selling shares of Ardent Health?

During the last twelve months, Ardent Health insiders bought shares 1 times. They purchased a total of 10,000 shares worth more than $88,100.00. The most recent insider tranaction occured on June, 5th when CFO Alfred Lumsdaine bought 10,000 shares worth more than $88,100.00. Insiders at Ardent Health own 1.9% of the company. Learn More about insider trades at Ardent Health.

Information on this page was last updated on 6/5/2026.

Alfred Lumsdaine Insider Trading History at Ardent Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/5/2026Buy10,000$8.81$88,100.00329,183View SEC Filing Icon  
See Full Table

Alfred Lumsdaine Buying and Selling Activity at Ardent Health

This chart shows Alfred Lumsdaine's buying and selling at Ardent Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ardent Health Company Overview

Ardent Health logo
Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
Read More

Today's Range

Now: $8.81
Low: $8.23
High: $8.83

50 Day Range

MA: $9.40
Low: $7.87
High: $10.26

2 Week Range

Now: $8.81
Low: $7.71
High: $15.48

Volume

901,794 shs

Average Volume

427,142 shs

Market Capitalization

$1.26 billion

P/E Ratio

9.28

Dividend Yield

N/A

Beta

0.84